CURRICULUM VITAE. (713) (O) B.S. in Biology, Fu-Jen Catholic University, Taiwan, R.O.C., 1974

Transcription

1 CURRICULUM VITAE NAME: Betty P. Tung BIRTH DATE: November 23, 1951 OFFICE (713) (O) EDUCATIONAL BACKGROUND: B.S. in Biology, Fu-Jen Catholic University, Taiwan, R.O.C., 1974 M.S. in Biometry, University of Texas School of Public Health, Texas, 1977 PROFESSIONAL EXPERIENCE Present Faculty Associate, The University of Texas School of Public Health Coordinating Center for Clinical Trials, Houston, Texas Present Project Manager/Statistician, Coordinating Center of Early Treatment for Retinopathy of Prematurity Project Manager/Statistician, Coordinating Center of Feasibility Trial of Light Reduction for Retinopathy of Prematurity Project Manager/Statistician, Coordinating Center of Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Teaching Assistant, Biostatistics, Regression Analysis, The University of Texas School of Public Health, Houston, Texas Statistician for the Hypertension Detection and Follow-up Program, plan and carry out data analyses for both internal use and for publication, prepare and present study reports Statistician and Programmer Analyst, The University of Texas School of Public Health, Lipid Research Project, Houston, Texas.

2 Page Research Statistical Aid, The University of Texas School of Public Health, Lipid Research Project, Houston, Texas. Department of Epidemiology. -- Compilation and summary in both tabular arrangement and graphic form for lipid data Technician, National Defense Medical Center, Taiwan, R.O.C. -- Microcomplement fixation test, immuno-electrophoresis data checking. HONORS: Four-year Scholarship in College PUBLICATIONS: Curb JD, Babcock C, Pressel S, Tung B, Remington RD, Hawkins CM: Nosological Coding of Cause of Death. American Journal of Epidemiology 118(1): , Langford H, Oberman A, Borhani N, Entwisle G, Tung B: Black-White Comparison of Indices of Coronary Heart Disease and Myocardial Infarction in the Stepped Care Cohort of the Hypertension Detection and Follow-up Program. American Heart Journal 108(3) part 2: , Hypertension Detection and Follow-up Program Cooperative Research Group: The Effect of Antihypertensive Drug Treatment on Mortality in the Presence of Resting Electrocardiographic Abnormalities at Baseline: The HDFP Experience. Circulation 70(6): , Curb JD, Borhani N, Entwisle G, Tung B, Kass E, Schnaper H, March Williams W, Berman R: Isolated Systolic Hypertension in 14 Communities. American Journal of Epidemiology 121(3): , Davis B, Curb JD, Tung B, Hawkins CM, Ehrman S, Farmer J, Martin M: Standardized Physician Preparation of Death Certificates. Controlled Clinical Trials 8: , Hypertension Detection and Follow-up Program Cooperative Research Group: Education Level and 5-Year All-Cause Mortality in the Hypertension Detection and Follow-up Program. Hypertension Vol 9, No. 6, June 1987.

3 Page 3 Prematurity--Preliminary results. Archives of Ophthalmology 106: , (also in Pediatrics 81(5): , 1988) Prematurity--Three Month Outcome. Archives of Ophthalmology 108: , Dobson V, Quinn GE, Biglan AW, Tung B, Flynn JT, Palmer EA: Acuity Card Assessment of Visual Function in the Cryotherapy for Retinopathy of Prematurity Trial. Investigative Ophthalmology & Visual Science 31: , Prematurity: One Year Outcome--Structure and Function. Archives of Ophthalmology 108: , Schaffer DB, Tung B, Hardy RJ: Guidelines for Follow-up for ROP. In Flynn JT, Tasman W(eds): Retinopathy of Prematurity for the Clinician, Springer-Verlag New York, Inc., New York, Phelps DL, Brown DR, Tung B, Cassady G, McClead RE, Purohit DM, Palmer EA: 28-day Survival rates of 6676 neonates with Birth Weights of 1250 Grams or Less. Pediatrics 87:7-17, Hardy RJ, Davis BR, Palmer EA, Tung B: Statistical Considerations in the Early Termination of the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Controlled Clinical Trials 12: , Palmer EA, Hardy RJ, Davis BR, Stein MA, Mowery RL, Tung B, Phelps DL, Schaffer DB, Flynn JT, Phillips CL: Operational Aspects of Early Termination of the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Controlled Clinical Trials 12: , Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, Tung B, on behalf of the Cryotherapy for Retinopathy of Pre-maturity Cooperative Group: Incidence and Early Course of Retinopathy of Prematurity. Ophthalmology 98: , Gilbert WS, Dobson V, Quinn GE, Reynolds J, Tung B, Flynn JT: The Correlation of Visual Function with Posterior Retinal Structure in Severe Retinopathy of Prematurity. Archives of Ophthalmology 110: , 1992.

4 Page 4 Summers GC, Phelps DL, Tung B, Palmer EA: Ocular Cosmesis in Retinopathy of Prematurity. Archives of Ophthalmology 110: , Schaffer DB, Palmer EA, Plotsky DF, Metz HS, Flynn JT, Tung B, Hardy RJ: Prognostic Factors in the Natural Course of Retinopathy of Prematurity (ROP). Ophthalmology 100: , Prematurity: 3 1/2-Year Outcome--Structure and Function. Archives of Ophthalmology 111: , Reynolds J, Dobson V, Quinn GE, Gilbert WS, Tung B, Robertson J, Flynn JT: Prediction of Visual Function in Eyes with Mild to Moderate Posterior Pole Residua of ROP. Archives of Ophthalmology 111: , The natural ocular outcome of premature birth and retinopathy: status at one year. Archives of Ophthalmology 112: , Dobson V, Quinn GE, Summer CG, Saunders RA, Phelps DL, Tung B, Palmer EA: Effect of Acute-phase Retinopathy of Prematurity on Grating Acuity Development in the very low Birth Weight Infants. Investigative Ophthalmology & Visual Science 35(13): , Dobson V, Quinn GE, Tung B, Palmer EA, Reynolds JD: Comparison of Recognition and Grating Acuity in very low Birth Weight Children with and without Retinal Residua of Retinopathy of Prematurity (ROP). Investigative Ophthalmology & Visual Science 36: ,1995. Kivlin JD, Biglan AW, Gordon RA, Dobson V, Hardy RA, Palmer EA, Tung B, Gilbert W, Spencer R, Cheng KP, Buckley E: Early Retinal Vessel Development as a Factor in Retinopathy of Prematurity and its Functional Sequelae. Archives of Ophthalmology 114: , Prematurity: Snellen Acuity and Structure Outcome at 5½ years. Archives of Ophthalmology 114: , Quinn GE, Dobson V, Barr CC, Davis BR, Palmer EA, Robertson J, Summer CG, Trese MT, Tung B: Visual Acuity of Eyes after Vitrectomy for ROP: Follow-up at 5½ years. Ophthalmology 103: , 1996.

5 Page 5 Quinn GE, Dobson V, Hardy RJ, Tung B, Phelps DL, Palmer EA: Visual Fields Measured with Double-Arc Perimetry in Eyes with Threshold Retinopathy of Prematurity (ROP) from the CRYO-ROP Trial. Ophthalmology 103: , Dobson V, Quinn GE, Abramov I, Hardy RJ, Tung B, Siatkowski RM, Phelps DL, Palmer EA: Color Vision Measured with Pseudoisochromatic Plates at 5½ years in Eyes of Children from the CRYO-ROP Study. Investigative Ophthalmology & Visual Science 37: , Saunders RA, Donohue M, Christmann LM, Pakalnis VA, Tung B, Hardy RJ, Phelps DL: Racial Variation in Retinopathy of Prematurity. Archives of Ophthalmology 115: , Bremer L, Fellows RR, Palmer EA, Baker JD, Hardy RJ, Tung B, Roger GL: Strabismus in Premature Infants in the First Year of Life. Archives of Ophthalmology 116: , Quinn GE, Dobson V, Kivlin J, Kaufman LM, Repka MX, Reynolds JD, Gordon RA, Hardy RJ, Tung B, Stone RA: Prevalence of Myopia between 3 Months and 5½ Years in Preterm Infants with and without Retinopathy of Prematurity Ophthalmology 105: , Repka MX, Summers CG, Palmer EA, Dobson V, Tung B, Davis B: The Incidence of Ophthalmological Interventions in children with Birth Weights Less Than 1251 grams. Results through 5½ Years Ophthalmology 105: , Dobson V, Quinn GE, Siatkowski RM, Baker JD, Hardy RJ, Reynolds JD, Trese MT, Tung B: Agreement Between Grating Acuity at Age 1 Year and Snellen Acuity at age 5½ years in the Pretern Child. Investigative Ophthalmology & VisualScience 40: , Harvey EM, Dobson V, Tung B, Quinn GE, Hardy RJ: Interobserver Agreement for Grating Acuity and Letter Acuity Assessment in 1- to 5½- year-old with Severe Retinopathy of Prematurity. Investigative Ophthalmology & VisualScience 40: LIGHT-ROP Cooperative Group: The Design of the Multicenter Study in Retinopathy of Prematurity: Journal of Pediatric Ophthalmology & Strabismus 36(5): , Repka MX, Palmer EA, Tung B: Involution of Retinopathy of Prematurity. Archives of Ophthalmology 118(5): ,2000. Msall ME, Phelps DL, DiGaudio KM, Dobson V, Tung B, McClead RE,

6 Page 6 Quinn GE, Reynolds JD, Hardy RJ, Palmer EA: Severity of Neonatal Retinopathy of Prematurity (ROP) is Predictive of Neurodevelopmental Functional Outcome at Age 5.5 Years. Pediatric 106: , Quinn GE, Dobson V, Siatkowski RM, Hardy RJ, Kivlin JD, Palmer EA, Phelps DL, Repka MX, Summers CG, Tung B, Chan W : Does Cryotherapy affect Refractive Error? Results from Treated and Control Eyes in the Cryotherapy for Retinopathy of Prematurity: Ophthalmology 108(2): ,2001. Ophthalmological Outcome at 10 years. Archives of Ophthalmology 119(8): ,2001. Effect of Ablative Cryotherapy for Threshold Retinopathy of Prematurity: Results of Goldmann Perimetry at age 10 years. Archives of Ophthalmology 119(8): ,2001. Contrast Sensitivity in Eyes with Threshold ROP from the CRYO-ROP Trial. Archives of Ophthalmology 119(8): , Kennedy K, Fielder AR, Hardy RJ, Tung B, Gordon D, Reynolds JD for the LIGHT-ROP Cooperative Group, Reduced Lighting Does not Improve Medical Outcome in Very-Low-Weight Infants. Journal of Pediatrics 139(4): ,2001. Multicenter trial of cryotherapy for retinopathy of prematurity: Natural history ROP: Ocular outcome at 5½ years in premature infants with birth weights less than 1251 g. Arch Ophthalmol 120: ,2002. Reynolds JD, Dobson V, Quinn GE, Fielder AR, Palmer EA, Saunders RA, Hardy RJ, Phelps DL, Baker JD, Trese MT, Schaffer DB, Tung B for the CRYO-ROP and LIGHT-ROP Cooperative Groups. Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol 120: ,2002. Hardy RJ, Palmer EA, Dobson V, Summers CG, Phelps DL, Quinn GE, Good W, Tung B. Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol 121: ,2003. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity (ROP): results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121: ,2003.

7 Page 7 Quinn GE, Dobson V, Saigal S, Phelps DL, Hardy RJ, Tung B, Summers GS, Palmer EA on Behalf of the CRYO-ROP Cooperative Group. Health related quality of life at age 10 years in very-lowbirth-weight with and without severe retinopathy of prematurity. Arch Ophthalmol 122: , Cryotherapy for Retinopathy of Prematurity Cooperative Group. Fifteen-year Outcomes following Threshold Retinopathy of Prematurity: Final Results from the Multicenter Trial of Cryotherapy. Arch Ophthalmol 123: , Early Treatment for Retinopathy of Prematurity Cooperative Group. The Incidence and Course of Retinopathy of Prematurity: Findings from the Early Treatment for Retinopathy of Prematurity Study. Pediatrics 116;15-23, Davitt BV, Dobson V, Good WV, Hardy RJ, Quinn GE, Siatkowski RM, Summers CG, Tung B, on behalf of the Early Treatment for Retinopathy of Prematurity Cooperative Group. Prevalence of Myopia at 9 Months in Infants with High-Risk Prethreshold Retinopathy of Prematurity: Results from the ETROP Trial. Ophthalmology 112(9); ,2005. Repka MX, Tung B, Good WV, Shapiro M, Capone A Jr, Baker JD, Barr CC, Phelps DL, van Heuven WAJ Outcome of Eyes Developing Retinal Detachment During the Early Treatment for Retinopathy of Prematurity Study (ETROP) Arch Ophthalmol, 124: 24 30, Cryotherapy for Retinopathy of Prematurity Cooperative Group. Visual acuity at 10 Years in the CRYO-ROP Study Eyes: Effect of retinal residua of ROP. Arch Ophthalmol, 124; , VanderVeen DK, Coats DK, Dobson V, Fredrick D, Gordon RA, Hardy RJ, Neely DE, Palmer EA, Steidl SM, Tung B, Good WV, MD; for the Early Treatment for Retinopathy of Prematurity Cooperative Group. Prevalence and Course of Strabismus in the First Year of Life for Infants With Prethreshold Retinopathy of Prematurity Arch Ophthalmol, 124: , Group. The early treatment for retinopathy of prematurity study (ETROP): structural findings at 2 years of age. Br J Ophthalmol, 90: , 2006.

8 Page 8 Hardy RJ, Good WV, Dobson V, Palmer EA, Tung B, Phelps DL, Shapiro MJ, van Heuven WAJ, on behalf of the ETROP Cooperative Group. The Early Treatment for Retinopathy of Prematurity Clinical Trial: Presentation by Subgroups versus Analysis within Subgroups. Br J Ophthalmol, 90: , PMC Siatkowski RM, Dobson V, Quinn GE, Summers CG, Tung B: Severe Visual Impairment in Children with Mild or Moderate Residua Following Regressed Threshold ROP. Journal of AAPOS, 11(2): , Quinn GE, Dobson V, Davitt BV, Hardy RJ, Tung B, Pedroza C, Good WV on behalf of the ETROP Cooperative Group. Progression of Myopia in the Early Treatment for Retinopathy of Prematurity Study: Findings to 3 Years of Age. Ophthalmology, 115(6): , Davitt BV, Quinn GE, Dobson V, Quinn GE, Hardy RJ, Tung B, Good WV on behalf of the Early Treatment for Retinopathy of Prematurity Cooperative Group. Astigmatism in the Early Treatment for Retinopathy of Prematurity Study: Findings to 3 Years of Age. Ophthalmology 116:332-9, PMC Christiansen SP, Dobson V, Quinn GE, Good WV, Tung B, Hardy RJ, Hoffman RO, Reynolds JD, Rychwalski PJ, Shapiro MJ. Progression of Type 2 to Type 1 ROP in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol, 128: , Group. Final Visual Acuity Results in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol, 128:E1-E9, Group. Final Visual Acuity Results in the Early Treatment for Retinopathy of Prematurity Study. Arch Ophthalmol, 128: , Wheeler DT, Dobson V, Chiang MF, Bremer DL, Gewolb IH, Phelps DL, Hardy RJ, Good WV, Fellows R, Tung B, Palmer EA. Retinopathy of Prematurity in Infants Weighing Less Than 500 Grams at Birth Enrolled in the Early Treatment for Retinopathy of Prematurity (ETROP) Study. Ophthalmol. January 4, 2011.

9 Page 9 Group. Visual Field Extend at Age 6 Years in Children who had High-Risk Prethreshold Retinopathy of Prematurity. Arch Ophthalmol. Accepted, Group. Grating Visual Acuity Results in the Early Treatment for Retinopathy Study. Arch Ophthalmol, Accepted, 2011.